Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21131037

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2010 Dec 11
First author
Morgan GJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2010 Dec 11;376(9757):1965-6. doi: 10.1016/S0140-6736(10)62178-2.
    note
    Source null
    related pmid
    21131042
    relationship
    Comment in
  2. citation
    Lancet. 2011 Jun 25;377(9784):2177-8. doi: 10.1016/S0140-6736(11)60958-6.
    note
    Source null
    related pmid
    21704864
    relationship
    Comment in
  3. citation
    Lancet. 2011 Jun 25;377(9784):2178. doi: 10.1016/S0140-6736(11)60959-8.
    note
    Source null
    related pmid
    21704866
    relationship
    Comment in

Authors and identifiers

  1. name
    Morgan GJ
    type
    Author
  2. name
    Davies FE
    type
    Author
  3. name
    Gregory WM
    type
    Author
  4. name
    Cocks K
    type
    Author
  5. name
    Bell SE
    type
    Author
  6. name
    Szubert AJ
    type
    Author
  7. name
    Navarro-Coy N
    type
    Author
  8. name
    Drayson MT
    type
    Author
  9. name
    Owen RG
    type
    Author
  10. name
    Feyler S
    type
    Author
  11. name
    Ashcroft AJ
    type
    Author
  12. name
    Ross F
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Morgan GJ
    type
    Author
  2. name
    Davies FE
    type
    Author
  3. name
    Gregory WM
    type
    Author
  4. name
    Cocks K
    type
    Author
  5. name
    Bell SE
    type
    Author
  6. name
    Szubert AJ
    type
    Author
  7. name
    Navarro-Coy N
    type
    Author
  8. name
    Drayson MT
    type
    Author
  9. name
    Owen RG
    type
    Author
  10. name
    Feyler S
    type
    Author
  11. name
    Ashcroft AJ
    type
    Author
  12. name
    Ross F
    type
    Author
bibliography ids
  1. nci-bib-b3af1878ea9480bb9b977f08
book metadata
content sha256
b62abb071095c2f1c94d03996fa0af53712283c57c9a8e9392938c5afcf28d95
document type
citation
dois
  1. 10.1016/S0140-6736(10)62051-X
electronic publication date
display
2010 Dec 3
precision
day
year
2010
evidence scope
bibliographic_metadata_only
id
pubmed:21131037
immutable id
pubmed:21131037@b62abb071095c2f1c94d03996fa0af53712283c57c9a8e9392938c5afcf28d95
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9757
name
Lancet (London, England)
nlm unique id
2985213R
pages
1989-99
volume
376
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2010 Dec 11;376(9757):1965-6. doi: 10.1016/S0140-6736(10)62178-2.
    note
    Source null
    related pmid
    21131042
    relationship
    Comment in
  2. citation
    Lancet. 2011 Jun 25;377(9784):2177-8. doi: 10.1016/S0140-6736(11)60958-6.
    note
    Source null
    related pmid
    21704864
    relationship
    Comment in
  3. citation
    Lancet. 2011 Jun 25;377(9784):2178. doi: 10.1016/S0140-6736(11)60959-8.
    note
    Source null
    related pmid
    21704866
    relationship
    Comment in
outcomes validated
false
pmid
21131037
provenance
batch id
edef4b7f1a2a505cd5a9
provider
NCBI PubMed ESummary
record sha256
9c4221ea9ebdef4339c90ec12c78c2fd711bd21e7f571426ddb967a2ada29e01
response sha256
d2d0fd7c34783716c953156f8a1da1b7b36c4823b416656eca04a1e69e03a295
retrieved at
2026-09-09T23:46:38.027615+00:00
publication date
display
2010 Dec 11
precision
day
year
2010
publication types
  1. Comparative Study
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21131037/
title
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.

Preserved source evidence · Not medical advice